{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:57Z","timestamp":1792787277974,"version":"4.5.0"},"reference-count":28,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"unspecified","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Fight for Sight-International Retinal Research Foundation","award":["FFSGIA16002"],"award-info":[{"award-number":["FFSGIA16002"]}],"id":[{"id":"https:\/\/ror.org\/04xsz1294","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Wilmer Eye Institute Department of Ophthalmology","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY033000"],"award-info":[{"award-number":["1R01EY033000"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1R01EY034325"],"award-info":[{"award-number":["1R01EY034325"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["F\/A"],"award-info":[{"award-number":["F\/A"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jonas Friedenwald Professorship in Ophthalmology","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100007817","name":"Alcon Research Institute","doi-asserted-by":"publisher","award":["Alcon Research Institute Young Investigator Grant"],"award-info":[{"award-number":["Alcon Research Institute Young Investigator Grant"]}],"id":[{"id":"10.13039\/100007817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2026,8,13]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to assess the association between systemic hypoxia and progression from non-proliferative diabetic retinopathy (NPDR) to proliferative diabetic retinopathy (PDR) and vision-threatening outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This retrospective cohort study used the TriNetX Network to identify adults with NPDR with no prior PDR. Systemic hypoxia was defined using International Classification of Diseases 10th revision (ICD-10) codes for anaemia, obstructive sleep apnoea, chronic respiratory failure, chronic obstructive pulmonary disease, pulmonary hypertension or interstitial lung disease. Both cohorts were propensity score-matched. The primary outcome was progression to PDR. Secondary outcomes included vitreous haemorrhage, tractional retinal detachment, legal blindness, diabetic macular oedema and therapeutic interventions. Time-to-event analyses were performed using Cox proportional hazards models, and 5-year cumulative incidence was assessed using Kaplan-Meier analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After matching, 92\u2009454 patients were included in each cohort with well-balanced baseline characteristics (all standardised mean differences &lt;0.1). Systemic hypoxia was associated with increased risk of PDR progression (HR 1.24; 95% CI 1.18 to 1.31; p&lt;0.001). 5-year cumulative PDR incidence was higher in the hypoxia cohort (4.2% vs 2.6%; risk ratio 1.63). Patients with systemic hypoxia also had higher risks of vitreous haemorrhage, tractional retinal detachment, blindness and increased utilisation of panretinal photocoagulation and pars plana vitrectomy. Subgroup analyses identified anaemia as the primary driver of PDR progression, whereas respiratory aetiologies were not independently associated after matching.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Systemic hypoxia, a diagnosis-code-based composite in which anaemia-associated phenotypes showed the strongest association, is associated with accelerated PDR progression and near-doubled legal blindness risk. Anaemia screening may offer an opportunity to reduce vision-threatening complications in diabetic patients. These findings are hypothesis-generating and warrant prospective validation before informing screening pathways, given the retrospective design and absence of measured oxygen saturation, haemoglobin and glycaemic data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2026-002941","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:25:10Z","timestamp":1789561510000},"page":"e002941","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Role of systemic hypoxia in the progression of diabetic retinopathy: a propensity-matched retrospective cohort study"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4743-7226","authenticated-orcid":false,"given":"Luqman","family":"Munir","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4325-3430","authenticated-orcid":false,"given":"Meltem","family":"Yashar","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathlyn","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayan","family":"Vaishnav","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA"},{"name":"Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannis M","family":"Paulus","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland, USA"},{"name":"Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026091605250771000_11.3.e002941.1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0792"},{"key":"2026091605250771000_11.3.e002941.2","first-page":"16","article-title":"Diabetic retinopathy: a growing concern in an aging population","volume":"64","author":"Paulus","year":"2009","journal-title":"Geriatrics"},{"key":"2026091605250771000_11.3.e002941.3","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1038\/s41433-023-02422-1","article-title":"Retinal neovascularization as self-organized criticality on ultra-widefield fluorescein angiography imaging of diabetic retinopathy","volume":"37","author":"Young","year":"2023","journal-title":"Eye (Lond)"},{"key":"2026091605250771000_11.3.e002941.4","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2147\/OPTH.S462223","article-title":"Quantitative Biomarkers of Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography","volume":"18","author":"Fleifil","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"2026091605250771000_11.3.e002941.5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12071405","article-title":"Advances in Structural and Functional Retinal Imaging and Biomarkers for Early Detection of Diabetic Retinopathy","volume":"12","author":"Zhang","year":"2024","journal-title":"Biomedicines"},{"key":"2026091605250771000_11.3.e002941.6","doi-asserted-by":"crossref","first-page":"4019","DOI":"10.2147\/OPTH.S472071","article-title":"Quantitative ultra-widefield fluorescein angiography biomarkers in diabetic retinopathy and association with treatment and progression","volume":"18","author":"Iyengar","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"2026091605250771000_11.3.e002941.7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jamaophthalmol.2020.1257","article-title":"Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced Disease","volume":"138","author":"Yu","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"2026091605250771000_11.3.e002941.8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.5664\/jcsm.9552","article-title":"Sleep apnea and eye diseases: evidence of association and potential pathogenic mechanisms","volume":"18","author":"Garc\u00eda-S\u00e1nchez","year":"2022","journal-title":"J Clin Sleep Med"},{"key":"2026091605250771000_11.3.e002941.9","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.3390\/ijms251810140","article-title":"Recent Insights into Roles of Hypoxia-Inducible Factors in Retinal Diseases","volume":"25","author":"Lee","year":"2024","journal-title":"IJMS"},{"key":"2026091605250771000_11.3.e002941.10","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-021-01425-0","article-title":"Obstructive Sleep Apnoea, Other Sleep Parameters and Diabetic Retinopathy","volume":"21","author":"Wei","year":"2021","journal-title":"Curr Diab Rep"},{"key":"2026091605250771000_11.3.e002941.11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41433-019-0617-6","article-title":"Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy","volume":"34","author":"Li","year":"2020","journal-title":"Eye (Lond)"},{"key":"2026091605250771000_11.3.e002941.12","doi-asserted-by":"crossref","unstructured":"Chung JO , Park S-Y , Chung DJ , et al . Relationship between anemia, serum bilirubin concentrations, and diabetic retinopathy in individuals with type 2 diabetes. Medicine (Baltimore) 2019;98. doi:10.1097\/MD.0000000000017693","DOI":"10.1097\/MD.0000000000017693"},{"key":"2026091605250771000_11.3.e002941.13","doi-asserted-by":"crossref","first-page":"101891","DOI":"10.1016\/j.smrv.2023.101891","article-title":"Multidimensional sleep health and diabetic retinopathy: Systematic review and meta-analysis","volume":"74","author":"Simonson","year":"2024","journal-title":"Sleep Med Rev"},{"key":"2026091605250771000_11.3.e002941.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1005073"},{"key":"2026091605250771000_11.3.e002941.15","first-page":"759","article-title":"Association between diabetic retinopathy and hemoglobin level","volume":"4","author":"Bahar","year":"2013","journal-title":"Caspian J Intern Med"},{"key":"2026091605250771000_11.3.e002941.16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnha.2025.100632","article-title":"Association between omega-3 fatty acid intake and risk of diabetic retinopathy: A systematic review and meta-analysis","volume":"29","author":"Chen","year":"2025","journal-title":"J Nutr Health Aging"},{"key":"2026091605250771000_11.3.e002941.17","doi-asserted-by":"crossref","first-page":"109178","DOI":"10.1016\/j.jdiacomp.2025.109178","article-title":"Can fibrate therapy redefine the management of diabetic retinopathy? A comprehensive systematic review and meta-analysis of efficacy and safety","volume":"39","author":"Chen","year":"2025","journal-title":"J Diabetes Complications"},{"key":"2026091605250771000_11.3.e002941.18","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000236"},{"key":"2026091605250771000_11.3.e002941.19","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic Retinopathy: Pathophysiology and Treatments","volume":"19","author":"Wang","year":"2018","journal-title":"IJMS"},{"key":"2026091605250771000_11.3.e002941.20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674343","article-title":"Association of Circulating Vascular Endothelial Growth Factor Levels With Autoimmune Diseases: A Systematic Review and Meta-Analysis","volume":"12","author":"Zhan","year":"2021","journal-title":"Front Immunol"},{"key":"2026091605250771000_11.3.e002941.21","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12112512","article-title":"Methylglyoxal: A Key Factor for Diabetic Retinopathy and Its Effects on Retinal Damage","volume":"12","author":"Klochkov","year":"2024","journal-title":"Biomedicines"},{"key":"2026091605250771000_11.3.e002941.22","doi-asserted-by":"crossref","unstructured":"Portol\u00e9s J , Mart\u00edn L , Broseta JJ , et al . Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents. Front Med 2021;8. doi:10.3389\/fmed.2021.642296","DOI":"10.3389\/fmed.2021.642296"},{"key":"2026091605250771000_11.3.e002941.23","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/ajh.26992","article-title":"Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis","volume":"98","author":"Song","year":"2023","journal-title":"Am J Hematol"},{"key":"2026091605250771000_11.3.e002941.24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajo.2024.07.021","article-title":"Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications","volume":"270","author":"Rahimy","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"2026091605250771000_11.3.e002941.25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.01063","article-title":"Stabilization of HIF-1\u03b1 in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors","volume":"11","author":"Lazzara","year":"2020","journal-title":"Front Pharmacol"},{"key":"2026091605250771000_11.3.e002941.26","doi-asserted-by":"publisher","DOI":"10.1007\/S00125-021-05380-Z"},{"key":"2026091605250771000_11.3.e002941.27","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002"},{"key":"2026091605250771000_11.3.e002941.28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.12.9.8","article-title":"Risk Factors and Outcomes of Delayed Presentation of Diabetic Retinopathy Patients to a County Hospital","volume":"12","author":"Lu","year":"2023","journal-title":"Trans Vis Sci Tech"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2026-002941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:25:17Z","timestamp":1789561517000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2026-002941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,9,16]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjophth-2026-002941"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2026-002941","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}